Acute deviations from long-term trait depressive symptoms predict systemic inflammatory activity

Brain, Behavior, and Immunity

Volumn 22, Issue 5, 2008, Pages 709-716

  Rohleder, Nicolas ^a   Miller, Gregory E ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Depression; Depressive mood; Inflammation; Interleukin 6; State; Trait

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; INFLAMMATION; INTERNET; MOOD CHANGE; PERSONALITY; PRIORITY JOURNAL; SELF CONCEPT;

ACUTE DISEASE; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DEPRESSION; DEPRESSIVE DISORDER; DISEASE SUSCEPTIBILITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; LINEAR MODELS; TIME FACTORS;

EID: 44749088383     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbi.2007.10.012     Document Type: Article

References (43)

1. Alloy L.B., Abramson L.Y., Whitehouse W.G., Hogan M.E., Tashman N.A., Steinberg D.L., Rose D.T., and Donovan P. Depressogenic cognitive styles: predictive validity, information processing and personality characteristics, and developmental origins. Behav. Res. Ther. 37 6 (1999) 503-531
2. Andresen E.M., Malmgren J.A., Carter W.B., and Patrick D.L. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am. J. Prev. Med. 10 (1994) 77-84
3. Bierhaus A., Wolf J., Andrassy M., Rohleder N., Humpert P.M., Petrov D., Ferstl R., von Eynatten M., Wendt T., Rudofsky G., Joswig M., Morcos M., Schwaninger M., McEwen B., Kirschbaum C., and Nawroth P.P. A mechanism converting psychosocial stress into mononuclear cell activation. Proc. Natl. Acad. Sci. USA 100 (2003) 1920-1925
4. Carney R.M., Blumenthal J.A., Freedland K.E., Youngblood M., Veith R.C., Burg M.M., Cornell C., Saab P.G., Kaufmann P.G., Czajkowski S.M., and Jaffe A.S. Depression and late mortality after myocardial infarction in the enhancing recovery in coronary heart disease (ENRICHD) study. Psychosom. Med. 66 (2004) 466-474
5. Carney R.M., Rich M.W., Freedland K.E., Saini J., teVelde A., Simeone C., and Clark K. Major depressive disorder predicts cardiac events in patients with coronary artery disease. Psychosom. Med. 50 (1988) 627-633
6. Danesh J. Smoldering arteries? Low-grade inflammation and coronary heart disease. JAMA 282 (1999) 2169-2171
7. Danner M., Kasl S.V., Abramson J.L., and Vaccarino V. Association between depression and elevated C-reactive protein. Psychosom. Med. 65 (2003) 347-356
8. de Groot M., Anderson R., Freedland K.E., Clouse R.E., and Lustman P.J. Association of depression and diabetes complications: a meta-analysis. Psychosom. Med. 63 (2001) 619-630
9. Dentino A.N., Pieper C.F., Rao M.K., Currie M.S., Harris T., Blazer D.G., and Cohen H.J. Association of interleukin-6 and other biologic variables with depression in older people living in the community. J. Am. Geriatr. Soc. 47 (1999) 6-11
10. Edwards K.M., Burns V.E., Ring C., and Carroll D. Sex differences in the interleukin-6 response to acute psychological stress. Biol. Psychol. 71 (2006) 236-239
11. Empana J.P., Sykes D.H., Luc G., Juhan-Vague I., Arveiler D., Ferrieres J., Amouyel P., Bingham A., Montaye M., Ruidavets J.B., Haas B., Evans A., Jouven X., and Ducimetiere P. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the prospective epidemiological study of myocardial infarction (PRIME). Circulation 111 (2005) 2299-2305
12. Ford D.E., and Erlinger T.P. Depression and C-reactive protein in US adults: data from the third national health and nutrition examination survey. Arch. Intern. Med. 164 (2004) 1010-1014
13. Frasure-Smith N., Lesperance F., and Talajic M. Depression following myocardial infarction. Impact on 6-month survival. JAMA 270 (1993) 1819-1825
14. Glaser R., Robles T.F., Sheridan J., Malarkey W.B., and Kiecolt-Glaser J.K. Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults. Arch. Gen. Psychiatry 60 (2003) 1009-1014
15. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 444 (2006) 860-867
16. Irwin M. Psychoneuroimmunology of depression: clinical implications. Brain Behav. Immun. 16 (2002) 1-16
17. Irwin M.R., and Miller A.H. Depressive disorders and immunity: 20 years of progress and discovery. Brain Behav. Immun. 21 (2007) 374-383
18. Kling M.A., Alesci S., Csako G., Costello R., Luckenbaugh D.A., Bonne O., Duncko R., Drevets W.C., Manji H.K., Charney D.S., Gold P.W., and Neumeister A. Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A. Biol. Psychiatry 62 (2007) 309-313
19. Kop W.J., Gottdiener J.S., Tangen C.M., Fried L.P., McBurnie M.A., Walston J., Newman A., Hirsch C., and Tracy R.P. Inflammation and coagulation factors in persons >65 years of age with symptoms of depression but without evidence of myocardial ischemia. Am. J. Cardiol. 89 (2002) 419-424
20. Lesperance F., Frasure-Smith N., Talajic M., and Bourassa M.G. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation 105 (2002) 1049-1053
21. Libby P., and Ridker P.M. Inflammation and atherothrombosis from population biology and bench research to clinical practice. J. Am. Coll. Cardiol. 48 (2006) A33-A46
22. Lustman P.J., Anderson R.J., Freedland K.E., de Groot M., Carney R.M., and Clouse R.E. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 23 (2000) 934-942
23. McCaffery J.M., Frasure-Smith N., Dube M.P., Theroux P., Rouleau G.A., Duan Q., and Lesperance F. Common genetic vulnerability to depressive symptoms and coronary artery disease: a review and development of candidate genes related to inflammation and serotonin. Psychosom. Med. 68 (2006) 187-200
24. McEwen B.S. Protective and damaging effects of stress mediators. N. Engl. J. Med. 338 (1998) 171-179
25. McEwen B.S., and Stellar E. Stress and the individual. Mechanisms leading to disease. Arch. Intern. Med. 153 (1993) 2093-2101
26. Miller G.E., and Blackwell E. Turning up the heat: inflammation as a mechanism linking chronic stress, depression, and heart disease. Curr. Dir. Psychol. Sci. 15 (2006) 269-272
27. Miller G.E., Freedland K.E., Duntley S., and Carney R.M. Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes. Am. J. Cardiol. 95 (2005) 317-321
28. Miller G.E., Rohleder N., Stetler C., and Kirschbaum C. Clinical depression and regulation of the inflammatory response during acute stress. Psychosom. Med. 67 (2005) 679-687
29. Miller G.E., Stetler C.A., Carney R.M., Freedland K.E., and Banks W.A. Clinical depression and inflammatory risk markers for coronary heart disease. Am. J. Cardiol. 90 (2002) 1279-1283
30. Mittermaier C., Dejaco C., Waldhoer T., Oefferlbauer-Ernst A., Miehsler W., Beier M., Tillinger W., Gangl A., and Moser G. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom. Med. 66 (2004) 79-84
31. Pace T.W., Mletzko T.C., Alagbe O., Musselman D.L., Nemeroff C.B., Miller A.H., and Heim C.M. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am. J. Psychiatry 163 (2006) 1630-1633
32. Panagiotakos D.B., Pitsavos C., Chrysohoou C., Tsetsekou E., Papageorgiou C., Christodoulou G., and Stefanadis C. Inflammation, coagulation, and depressive symptomatology in cardiovascular disease-free people; the ATTICA study. Eur. Heart J. 25 (2004) 492-499
33. Radloff L.S. The CES-D scale: a self report depression scale for research in the general population. Appl. Psychol. Meas. 1 (1977) 385-401
34. Rohleder N., Schommer N.C., Hellhammer D.H., Engel R., and Kirschbaum C. Sex differences in glucocorticoid sensitivity of proinflammatory cytokine production after psychosocial stress. Psychosom. Med. 63 (2001) 966-972
35. Rohleder N., Wolf J.M., and Kirschbaum C. Glucocorticoid sensitivity in humans-interindividual differences and acute stress effects. Stress 6 (2003) 207-222
36. Rugulies R. Depression as a predictor for coronary heart disease. a review and meta-analysis. Am. J. Prev. Med. 23 (2002) 51-61
37. Shimbo D., Chaplin W., Crossman D., Haas D., and Davidson K.W. Role of depression and inflammation in incident coronary heart disease events. Am. J. Cardiol. 96 (2005) 1016-1021
38. Steptoe A., Hamer M., and Chida Y. The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain Behav. Immun. 21 (2007) 901-912
39. von Kanel R., Kudielka B.M., Preckel D., Hanebuth D., and Fischer J.E. Delayed response and lack of habituation in plasma interleukin-6 to acute mental stress in men. Brain Behav. Immun. 20 (2006) 40-48
40. Weissmann, A., Beck, A.T., 1978. Development and validation of the dysfunctional attitudes scale: a preliminary evaluation. Paper presented at the meeting of the American Educational Research Association, Toronto, Canada.
41. Yudkin J.S., Kumari M., Humphries S.E., and Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis 148 (2000) 209-214
42. Zautra A.J., Parrish B.P., Van Puymbroeck C.M., Tennen H., Davis M.C., Reich J.W., and Irwin M. Depression history, stress, and pain in rheumatoid arthritis patients. J. Behav. Med. 30 (2007) 187-197
43. Zautra A.J., Yocum D.C., Villanueva I., Smith B., Davis M.C., Attrep J., and Irwin M. Immune activation and depression in women with rheumatoid arthritis. J. Rheumatol. 31 (2004) 457-463